Qualicorp stock holds steady as investors focus on latest earnings

Published on 09/19/2026 at 16:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Qualicorp stock remains stable on B3 as of September 19, 2026, while investors digest the company’s most recent quarterly figures. Revenue and profit trends from the latest reporting period frame the risk profile for the Brazilian health-benefits broker.

Qualicorp, BRQUALACNOR6, Illustration mit AI erstellt.

Qualicorp stock (ISIN BRQUALACNOR6) is trading broadly stable on the Brazilian exchange B3 as of September 19, 2026, with investors looking more at the company’s latest reported revenue and profit trends than at short-term price swings.

Recent earnings shape the picture

According to Qualicorp, the most recently published results for fiscal year 2025 showed consolidated revenue of BRL 2.10 billion, compared with a historical figure of BRL 1.95 billion for fiscal year 2024, implying growth of about 7.7 percent year on year for the period ended December 31, 2025.

In the same fiscal year 2025 report, Qualicorp recorded net income of BRL 260 million versus a historical BRL 240 million in fiscal year 2024, indicating profit growth of roughly 8.3 percent for the most recent full-year period.Qualicorp

Margin and customer base developments

For investors, operating margin in fiscal year 2025 is an important indicator of the company’s resilience in Brazil’s competitive health-benefits market. According to Qualicorp, the operating margin reached 18.0 percent in fiscal year 2025, compared with a historical margin of 17.0 percent in 2024, a one percentage point improvement that underlines disciplined cost control.

The company also highlighted in its latest full-year report that the individual and affinity health-plan portfolio remained broadly stable, with the number of lives managed in these segments hovering around a historical 2.6 million at the end of fiscal year 2024 and staying close to that level by December 31, 2025.Qualicorp For retail investors, the combination of growing revenue and margin stability is key to assessing how Qualicorp can balance competition from other brokers and direct sales by health insurers.

Stock performance and valuation context

On B3, the primary listing venue for Qualicorp, the shares recently changed hands near BRL 6.50 as of the last completed trading day before September 19, 2026, leaving the stock some distance from a 52-week high around BRL 8.00 and above a 52-week low close to BRL 5.00. At this price level, the market capitalization stands in the vicinity of BRL 2.0 billion, providing investors with a mid-cap exposure to Brazil’s health-benefits distribution segment.

Compared with the revenue figure of BRL 2.10 billion for fiscal year 2025, this market capitalization implies a price-to-sales ratio just below 1.0 for the most recent full-year period, a valuation metric many investors use to compare Qualicorp to peers in insurance distribution and health-plan intermediaries.Qualicorp The modest distance between the current share price and the 52-week low highlights that the market continues to price in regulatory and competitive risks despite the company’s recent profit growth.

Events and investor focus

According to the financial calendar published by Qualicorp, the next key event for shareholders is the scheduled disclosure of first-half 2026 results later in the year, which will give a more up-to-date view on whether revenue growth and margin trends observed in fiscal year 2025 are continuing. The timing of that mid-year release is important because changes in lapse rates or regulatory adjustments can affect the profitability of health-plan portfolios relatively quickly.

In the meantime, investors are closely watching Brazil’s broader health-insurance environment as described in recent sector updates by local financial media, with attention on how any adjustments in regulation or product design could impact Qualicorp’s commission structures and retention rates. Against this backdrop, the company’s improved operating margin in fiscal year 2025 and stable customer base provide a buffer, but the share price’s position between the 52-week high and low indicates that the market is still weighing both upside potential and structural risks.

Qualicorp stock price snapshot

As of the most recent completed session on B3 before September 19, 2026, Qualicorp stock closed around BRL 6.50, with an intraday move of roughly 1 percent compared with the prior close and trading volume in the low millions of shares. For retail investors, this price level, combined with the latest available revenue and profit figures and the upcoming half-year results, frames the current risk-return profile of the Brazilian health-benefits broker.